Senior insider sale
SVP, Chief Medical Officer at REATA PHARMACEUTICALS INC — senior position signals high conviction
$85.2K
688.00 shares
What this filing means
KHAN SAMINA plans to sell 688.00 shares of REATA PHARMACEUTICALS INC valued at approximately $85.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/16/2023ACC: 0001964306-23-000173
Officer· SVP, Chief Medical Officer
Since Feb 2022
688.00
Shares to sell
$85.2K
Approx. market value
336.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
8/15/2023
336.00Total acquired336.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 336.00 | — |
| Total | 336.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
352.00
Market value
$28.6K
5/16/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
336.00
Market value
$56.6K
8/16/2023
Total
Units
688.00
Value
$85.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/16/2023 | 352.00 | $28.6K | — | Completed |
| Planned — Approximate Date | ||||
8/16/2023 | 336.00 | $56.6K | NASDAQ | Planned |
| Total | 688.00 | $85.2K | ||